Satudora Holdings Co.,Ltd. (3544.T)
JPY 781.0
(-1.14%)
JPY 781.0
(-1.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.71 Billion JPY | 56.58% |
| 2022 | 1.57 Billion JPY | -17.01% |
| 2021 | 1.72 Billion JPY | 13.98% |
| 2020 | 2.21 Billion JPY | -15.51% |
| 2019 | 1.75 Billion JPY | 22.08% |
| 2018 | 1.9 Billion JPY | -6.68% |
| 2017 | 1.56 Billion JPY | -27.93% |
| 2016 | 2.44 Billion JPY | 32.02% |
| 2015 | 1.99 Billion JPY | 30.61% |
| 2014 | 1.5 Billion JPY | -11.57% |
| 2013 | 1.73 Billion JPY | -5.74% |
| 2012 | 1.83 Billion JPY | 7.38% |
| 2011 | 1.65 Billion JPY | 0.0% |
| 2010 | - JPY | -100.0% |
| 2009 | 1.36 Billion JPY | 50.18% |
| 2008 | 837.31 Million JPY | -25.86% |
| 2007 | 1.12 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 563.75 Million JPY | 511.22% |
| 2023 FY | - JPY | 56.58% |
| 2023 Q3 | 580 Million JPY | 30.04% |
| 2023 Q2 | 446 Million JPY | 102.73% |
| 2023 Q4 | 814 Million JPY | 40.34% |
| 2023 Q1 | 220 Million JPY | 21900.0% |
| 2022 Q1 | 106 Million JPY | -71.12% |
| 2022 FY | - JPY | -17.01% |
| 2022 Q4 | 1 Million JPY | -97.06% |
| 2022 Q3 | 34 Million JPY | -89.97% |
| 2022 Q2 | 339 Million JPY | 219.81% |
| 2021 Q4 | 367 Million JPY | 105.03% |
| 2021 Q1 | 88 Million JPY | -48.84% |
| 2021 Q2 | 250 Million JPY | 184.09% |
| 2021 Q3 | 179 Million JPY | -28.4% |
| 2021 FY | - JPY | 13.98% |
| 2020 Q1 | 150 Million JPY | -41.41% |
| 2020 Q2 | 181 Million JPY | 20.67% |
| 2020 Q3 | 164 Million JPY | -9.39% |
| 2020 Q4 | 172 Million JPY | 4.88% |
| 2020 FY | - JPY | -15.51% |
| 2019 Q1 | 3 Million JPY | -96.7% |
| 2019 FY | - JPY | 22.08% |
| 2019 Q4 | 256 Million JPY | -48.07% |
| 2019 Q3 | 493 Million JPY | 144.06% |
| 2019 Q2 | 202 Million JPY | 6633.33% |
| 2018 Q3 | 130 Million JPY | -12.75% |
| 2018 Q2 | 149 Million JPY | -1.32% |
| 2018 Q1 | 151 Million JPY | -40.78% |
| 2018 FY | - JPY | -6.68% |
| 2018 Q4 | 91 Million JPY | -30.0% |
| 2017 FY | - JPY | -27.93% |
| 2017 Q3 | 348 Million JPY | 155.88% |
| 2017 Q2 | 136 Million JPY | 23.64% |
| 2017 Q4 | 255 Million JPY | -26.72% |
| 2017 Q1 | 110 Million JPY | -55.28% |
| 2016 Q3 | 286 Million JPY | -38.63% |
| 2016 Q4 | 246 Million JPY | -13.99% |
| 2016 FY | - JPY | 32.02% |
| 2016 Q1 | 404 Million JPY | 55.98% |
| 2016 Q2 | 466 Million JPY | 15.35% |
| 2015 Q2 | 277 Million JPY | -38.99% |
| 2015 FY | - JPY | 30.61% |
| 2015 Q4 | 259 Million JPY | -13.09% |
| 2015 Q1 | 454 Million JPY | 427.91% |
| 2015 Q3 | 298 Million JPY | 7.58% |
| 2014 FY | - JPY | -11.57% |
| 2014 Q2 | 72.06 Million JPY | -80.1% |
| 2014 Q1 | 362.11 Million JPY | 170.22% |
| 2014 Q4 | 86 Million JPY | -56.35% |
| 2014 Q3 | 197.02 Million JPY | 173.4% |
| 2013 Q4 | 134 Million JPY | -51.63% |
| 2013 FY | - JPY | -5.74% |
| 2013 Q3 | 277.06 Million JPY | 7.57% |
| 2013 Q2 | 257.57 Million JPY | -36.66% |
| 2013 Q1 | 406.63 Million JPY | 151.74% |
| 2012 Q1 | 457.06 Million JPY | 188.05% |
| 2012 FY | - JPY | 7.38% |
| 2012 Q4 | 161.52 Million JPY | -50.25% |
| 2012 Q3 | 324.7 Million JPY | 11.41% |
| 2012 Q2 | 291.43 Million JPY | -36.24% |
| 2011 FY | - JPY | 0.0% |
| 2011 Q2 | 379.02 Million JPY | -26.11% |
| 2011 Q3 | 419.09 Million JPY | 10.57% |
| 2011 Q4 | 158.67 Million JPY | -62.14% |
| 2011 Q1 | 512.92 Million JPY | 28.57% |
| 2010 Q1 | 468.03 Million JPY | 45.81% |
| 2010 FY | - JPY | -100.0% |
| 2010 Q4 | 398.95 Million JPY | 0.0% |
| 2010 Q2 | 355.98 Million JPY | -23.94% |
| 2009 Q1 | 413.03 Million JPY | 9.65% |
| 2009 Q2 | 354.46 Million JPY | -14.18% |
| 2009 Q3 | 221.39 Million JPY | -37.54% |
| 2009 FY | - JPY | 50.18% |
| 2009 Q4 | 320.99 Million JPY | 44.99% |
| 2008 Q3 | 118.77 Million JPY | -41.57% |
| 2008 Q1 | 288.69 Million JPY | 0.0% |
| 2008 FY | - JPY | -25.86% |
| 2008 Q2 | 203.27 Million JPY | -29.59% |
| 2008 Q4 | 376.68 Million JPY | 217.15% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 287.258% |
| Cawachi Limited | 11.85 Billion JPY | 77.118% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -30.01% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 80.916% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 97.233% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 95.99% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 88.862% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 81.494% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 94.726% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 95.965% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | 28.931% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 91.149% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | 61.235% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | 35.244% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 94.656% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | 66.777% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | 34.999% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 81.263% |
| Ain Holdings Inc. | 31.22 Billion JPY | 91.314% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 95.178% |